- Home
- ABSI vs SOR Comparison
ABSI vs SOR Comparison
Compare ABSI & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.91
Company Overview
Basic Information| Metric | ABSI | SOR |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.9M | 391.5M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ABSI | SOR |
|---|---|---|
| Price | $2.91 | $45.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.98 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 11.4K |
| Earning Date | 03-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $10.72 | N/A |
| Revenue Next Year | $313.07 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $38.66 |
| 52 Week High | $5.23 | $50.41 |
Technical Indicators
Market Signals| Indicator | ABSI | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 28.23 |
| Support Level | $2.45 | $42.17 |
| Resistance Level | $3.29 | $45.04 |
| Average True Range (ATR) | 0.21 | 1.30 |
| MACD | 0.07 | -0.21 |
| Stochastic Oscillator | 71.35 | 2.45 |
Price Performance
Historical Comparison ABSI
SOR
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.